{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T16:28:52Z","timestamp":1747153732327,"version":"3.40.5"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T00:00:00Z","timestamp":1702684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T00:00:00Z","timestamp":1702684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Do cell phone text reminders impact the rate of compliance with pneumatic compression device (PCD) therapy among women with breast cancer-related lymphedema (BCRL)?<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A prospective, randomized, 2-group feasibility study conducted at 2 centers. Participants were adult females (\u226518 years old) with unilateral BCRL who had the capability of receiving reminder text messages. All participants underwent PCD therapy. Participants were randomized 1:1 to control (no text messages) or test group (received text message reminders if the PCD had not been used for 2 consecutive days). The rate of compliance between treatment groups was the main outcome measure. Secondary outcome measures were changes in arm girth, quality of life (QOL), and symptom severity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Twenty-nine participants were enrolled and randomized, 25 were available for follow-up at 60 days (14 test, 11 control). Overall, 52.2% (12\/23) of all participants were completely compliant, an additional 43.5% (10\/23) were partially compliant, and 1 patient (4.3%) was noncompliant. The test and control groups did not differ in device compliance. In the pooled population, weight, BMI, and arm girth were improved. Overall disease-specific QOL and symptom severity were improved. Regression analysis showed benefits were greater among participants with higher rates of compliance.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Automated text reminders did not improve compliance in patients with BCRL as compliance rates were already high in this patient population. Improvements in weight, BMI, arm girth, disease-specific quality of life, and symptom severity measures were observed regardless of the treatment assignment. Full compliance resulted in greater functional and QOL benefits.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>The study was registered at <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.clinicaltrials.gov\">www.clinicaltrials.gov<\/jats:ext-link> (NCT04432727) on June 16, 2020.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00520-023-08246-9","type":"journal-article","created":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T04:24:34Z","timestamp":1702700674000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of text reminders on pneumatic compression device (PCD) compliance in patients with breast cancer-related lymphedema"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8230-4088","authenticated-orcid":false,"given":"Shail","family":"Maingi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3751-764X","authenticated-orcid":false,"given":"Ellen M.","family":"O\u2019Malley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,16]]},"reference":[{"issue":"2","key":"8246_CR1","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1089\/lrb.2013.0033","volume":"12","author":"M Zaleska","year":"2014","unstructured":"Zaleska M, Olszewski WL, Durlick M (2014) The effectiveness of intermittent pneumatic compression in long-term therapy of lymphedema of lower limbs. Lymphat Res Biol 12(2):103\u2013109. https:\/\/doi.org\/10.1089\/lrb.2013.0033","journal-title":"Lymphat Res Biol"},{"issue":"1","key":"8246_CR2","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41523-021-00276-y","volume":"7","author":"MG Jorgensen","year":"2021","unstructured":"Jorgensen MG, Toyserkani NM, Hansen FG, Bygum A, Sorensen JA (2021) The impact of lymphedema on health-related quality of life up to 10 years after breast cancer treatment. NPJ Breast Cancer 7(1):70. https:\/\/doi.org\/10.1038\/s41523-021-00276-y","journal-title":"NPJ Breast Cancer"},{"issue":"1","key":"8246_CR3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/01893697-201432010-00005","volume":"32","author":"M Perdomo","year":"2014","unstructured":"Perdomo M, Davies C, Levenhagen K, Ryans K (2014) Breast cancer edge task force outcomes: Assessment measures of secondary lymphedema in breast cancer survivors. Rehabil Oncol 32(1):22\u201335. https:\/\/doi.org\/10.1097\/01893697-201432010-00005","journal-title":"Rehabil Oncol"},{"issue":"2","key":"8246_CR4","doi-asserted-by":"publisher","first-page":"pkz11","DOI":"10.1093\/jncics\/pkz011","volume":"3","author":"DA Young-Afat","year":"2019","unstructured":"Young-Afat DA, Gregorowitsch ML, van den Bongard DH, Burgmans I, van der Pol CC, Witkamp AJ, Bijlsma RM, Koelemij R, Schoenmaeckers EJ, Jonasse Y, van Gils CH, Verkooijen HM (2019) Breast edema following breast-conserving surgery and radiotherapy: patient-reported prevalence, determinants, and effect on health-related quality of life. JNCI Cancer Spectr 3(2):pkz11 https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6649691\/","journal-title":"JNCI Cancer Spectr"},{"issue":"1","key":"8246_CR5","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1186\/s12885-020-07079-7","volume":"20","author":"E Torgbenu","year":"2020","unstructured":"Torgbenu E, Luckett T, Buhagiar MA, Change S, Phillips JL (2020) Prevalence and incidence of cancer related lymphedema in low and middle-income countries: a systematic review and meta-analysis. BMC Cancer 20(1):604 https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-020-07079-7","journal-title":"BMC Cancer"},{"issue":"1","key":"8246_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10549-023-06947-7","volume":"200","author":"PM Donahue","year":"2023","unstructured":"Donahue PM, MacKenzie A, Filipovic A, Koelmeyer L (2023) Advances in the prevention and treatment of breast cancer-related lymphedema. Breast Cancer Res Treat 200(1):1\u201314 https:\/\/pubmed.ncbi.nlm.nih.gov\/37103598\/","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"8246_CR7","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/j.1365-2354.2007.00878.x","volume":"17","author":"D Langbecker","year":"2008","unstructured":"Langbecker D, Hayes SC, Newman B, Janda M (2008) Treatment for upper limb and lower limb lymphedema by professionals specializing in lymphedema care. Eur J Cancer Care (Engl) 17(6):557\u2013564. https:\/\/doi.org\/10.1111\/j.1365-2354.2007.00878.x","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"12","key":"8246_CR8","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1007\/s00520-012-1455-2","volume":"20","author":"CE Fife","year":"2012","unstructured":"Fife CE, Davey S, Maus EA, Guilliod R, Mayrovitz HN (2012) A randomized controlled trial comparing two types of pneumatic compression for breast cancer related lymphedema treatment in the home. Support Care Cancer 20(12):3279\u20133286. https:\/\/doi.org\/10.1007\/s00520-012-1455-2","journal-title":"Support Care Cancer"},{"issue":"3","key":"8246_CR9","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1089\/lrb.2014.0038","volume":"13","author":"M Zaleska","year":"2015","unstructured":"Zaleska M, Olszewski WL, Durlik M, Kaczmarek M (2015) A novel clinical test for setting intermittent pneumatic compression parameters based on edema fluid hydromechanics in the lymphedematous calf. Lymphat Res Biol 13(3):208\u2013214. https:\/\/doi.org\/10.1089\/lrb.2014.0038","journal-title":"Lymphat Res Biol"},{"key":"8246_CR10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.avsg.2015.07.004","volume":"30","author":"SN Blumberg","year":"2016","unstructured":"Blumberg SN, Berland T, Rockman C, Mussa F, Brooks A, Cayne N, Maldonado T (2016) Pneumatic compression improves quality of life in patients with lower extremity lymphedema. Ann Vasc Surg 30:40\u201344. https:\/\/doi.org\/10.1016\/j.avsg.2015.07.004","journal-title":"Ann Vasc Surg"},{"issue":"4","key":"8246_CR11","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.ejvs.2013.07.012","volume":"46","author":"SC Muluk","year":"2013","unstructured":"Muluk SC, Hirsch AT, Taffe EC (2013) Pneumatic compression device treatment of lower extremity lymphedema elicits improved limb volume and patient-reported outcomes. Eur J Vasc Endovasc Surg 46(4):480\u2013487. https:\/\/doi.org\/10.1016\/j.ejvs.2013.07.012","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"4","key":"8246_CR12","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1188\/08.ONF.671-680","volume":"35","author":"SH Ridner","year":"2008","unstructured":"Ridner SH, McMahon E, Dietrich MS, Hoy S (2008) Home based lymphedema treatment in patients with cancer-related lymphedema or noncancer-related lymphedema. Oncol Nurs Forum 35(4):671\u2013680. https:\/\/doi.org\/10.1188\/08.ONF.671-680","journal-title":"Oncol Nurs Forum"},{"key":"8246_CR13","first-page":"1","volume-title":"Barriers and facilitators to successful lymphedema therapy: the role of adherence","author":"SC Palmer","year":"2006","unstructured":"Palmer SC. (2006) Barriers and facilitators to successful lymphedema therapy: the role of adherence. Lymph Link 18(4):1-5. http:\/\/klosetraining.com\/wp-content\/uploads\/2013\/10\/Barriers-And-Faciliators-To-Successful-Lymphedema-Therapy-The-Role-of-Adherence-SC-Palmer-October-2006.pdf"},{"issue":"1","key":"8246_CR14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00520-013-1962-9","volume":"22","author":"JC Brown","year":"2014","unstructured":"Brown JC, Cheville AL, Tchou JC, Harris SR, Schmitz KH (2014) Prescription and adherence to lymphedema self-care modalities among women with breast cancer-related lymphedema. Support Care Cancer 22(1):135\u2013143. https:\/\/doi.org\/10.1007\/s00520-013-1962-9","journal-title":"Support Care Cancer"},{"issue":"1","key":"8246_CR15","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00520-014-2321-1","volume":"23","author":"KA Sherman","year":"2015","unstructured":"Sherman KA, Miller SM, Roussi P, Taylor A (2015) Factors predicting adherence to risk management behaviors of women at increased risk for developing lymphedema. Support Care Cancer 23(1):61\u201369 https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4270823\/","journal-title":"Support Care Cancer"},{"issue":"22","key":"8246_CR16","doi-asserted-by":"publisher","first-page":"12056","DOI":"10.3390\/ijerph182212056","volume":"18","author":"S Roca","year":"2021","unstructured":"Roca S, Lozano ML, Garcia J, Alesanco A (2021) Validation of a virtual assistant for improving medication adherence in patients with comorbid type 2 diabetes mellitus and depressive disorder. Int J Environ Res Public Health 18(22):12056. https:\/\/doi.org\/10.3390\/ijerph182212056","journal-title":"Int J Environ Res Public Health"},{"issue":"10","key":"8246_CR17","doi-asserted-by":"publisher","first-page":"7511","DOI":"10.1007\/s00464-022-09183-0","volume":"36","author":"M Ghio","year":"2022","unstructured":"Ghio M, Simpson JT, Wolff D, Galvani C, Levy S (2022) Tulane STAR (Sending Texts, Advancing Results): impact of text messaging on bariatric post-operative protocol compliance. Surg Endosc 36(10):7511\u20137515. https:\/\/doi.org\/10.1007\/s00464-022-09183-0","journal-title":"Surg Endosc"},{"issue":"2","key":"8246_CR18","doi-asserted-by":"publisher","first-page":"e33062","DOI":"10.2196\/33062","volume":"24","author":"A Ridho","year":"2022","unstructured":"Ridho A, Alfian SD, Van Boven JF, Letiva J, Yalcin EA, Le L, Alffenaar JW, Hak E, Abdulah R, Pradipta IS (2022) Digital health technologies to improve medication adherence and treatment outcomes in patients with tuberculosis: systematic review of randomized controlled trials. J Med Internet Res 24(2):e33062. https:\/\/doi.org\/10.2196\/33062","journal-title":"J Med Internet Res"},{"key":"8246_CR19","first-page":"26","volume":"5","author":"V Keeley","year":"2010","unstructured":"Keeley V, Crooks S, Locke J, Veigas D, Riches K, Hilliam R (2010) A quality of life measure for limb lymphedema (LYMQOL). J Lymphoedema 5:26\u201337 https:\/\/oro.open.ac.uk\/32567\/","journal-title":"J Lymphoedema"},{"issue":"10","key":"8246_CR20","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1007\/s00520-015-2684-y","volume":"23","author":"SH Ridner","year":"2015","unstructured":"Ridner SH, Dietrich MS (2015) Development and validation of the lymphedema symptom and intensity survey-arm. Support Care Cancer 23(10):3103\u20133112. https:\/\/doi.org\/10.1007\/s00520-015-2684-y","journal-title":"Support Care Cancer"},{"issue":"3","key":"8246_CR21","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/hec.4730020305","volume":"2","author":"RD Hays","year":"1993","unstructured":"Hays RD, Sherbourne CD, Mazel RM (1993) The RAND 36-Item Health Survey 1.0. Health Econ 2(3):217\u2013227. https:\/\/doi.org\/10.1002\/hec.4730020305","journal-title":"Health Econ"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-023-08246-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-023-08246-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-023-08246-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T15:06:29Z","timestamp":1705417589000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-023-08246-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,16]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["8246"],"URL":"https:\/\/doi.org\/10.1007\/s00520-023-08246-9","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"type":"print","value":"0941-4355"},{"type":"electronic","value":"1433-7339"}],"subject":[],"published":{"date-parts":[[2023,12,16]]},"assertion":[{"value":"21 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval was granted by Western IRB (Puyallup, WA) and University of Louisville Human Subjects Protection Program Office (Louisville, KY). This study was performed in line with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"EMO was paid by Tactile Medical to assist the lead author with the writing and preparation of the manuscript. SM has no conflicts to report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33"}}